Drug
Mvt 5873
Mvt 5873: highest development phase Phase 1, developed by BioNTech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioNTech
Trials
| Drug | Phase | Indication |
|---|---|---|
| MVT-5873 NCT02672917 | Phase 1 | Pancreatic Cancer |
Latest
No recent events.
Follow Mvt 5873 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.